Multiorgan Involvement in COVID-19 and Possible Therapies
Keyword(s):
AbstractIn late 2019, China reported cases of respiratory illness in humans, which involved a novel Coronavirus SARS-CoV-2 (also known as 2019-nCoV). The World Health Organization (WHO) termed the disease COVID-19 (i.e., Coronavirus disease 2019). Most of the morbidity and mortality from COVID-19 is largely due to acute viral pneumonitis that leads to acute respiratory distress syndrome (ARDS). This article will discuss the clinical features of the multiorgan involvement in COVID-19 as well as the management of patients who become critically ill due to COVID-19.
Keyword(s):
2020 ◽
Vol 21
(21)
◽
pp. 8081
◽
2020 ◽
Vol 10
(1)
◽
pp. 1-8
Keyword(s):
2021 ◽
pp. 498-500